The order by the Delhi High Court (HC) against US-based PayPal regarding mandatory compliance with the Prevention of Money Laundering Act (PMLA) on Monday is set to raise the regulatory expenses for payment operators in India according to a report by the Economic Times.
The ruling implies that payment companies, even those providing only a technology layer on top of banks without handling funds themselves, will now have to adhere to the PMLA guidelines. They will be required to periodically report high-value and suspicious transactions to the Financial Intelligence Unit.
Also Read: As Tata reimagines Air India brand, its Maharaja mascot may become history
Also Read: As Tata reimagines Air India brand, its Maharaja mascot may become history
Until now, many payment operators only had to follow the guidelines under the Payment and Settlement Systems Act enforced by the central bank. However, with the recent court order, even technology service providers facilitating money transfers between two parties fall under the ambit of payment systems and must comply with PML regulations.
Legal experts have expressed differing opinions on the ruling added the ET report. Some believe it will increase the cost of compliance, especially for small businesses in the low-margin payment industry. On the other hand, proponents argue that such compliance measures are essential to prevent money laundering and ensure financial security.
Also Read: Women workers to be impacted more than men by AI wave, says McKinsey
Also Read: Women workers to be impacted more than men by AI wave, says McKinsey
Larger payment companies were already voluntarily reporting to the Financial Intelligence Unit, but the recent ruling now mandates such reporting for all payment operators. This move aims to bring clarity and uniformity in the industry regarding anti-money laundering measures.
While payment applications transitioning into payment aggregators or gateways have already started reporting suspicious transactions in line with the new regulations, most operators are awaiting in-principle approval to operate as payment aggregators.
Also Read: Indian pharma to grow at 7-9% in FY24 despite regulatory risks: ICRA
Also Read: Indian pharma to grow at 7-9% in FY24 despite regulatory risks: ICRA